Clinical Specialties Compounding Pharmacy Recalls Testosterone Cypionate Due to Sterility Concerns
Clinical Specialties Compounding Pharmacy is recalling 12ml vials of Test cyp 50 mg/ml due to FDA inspection findings regarding quality control and lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, an FDA Class II recall involving a drug with sterility concerns (which implies a risk of infection or hospitalization) falls under the 'Severe' category, as it is not a Class I recall but involves significant health risks.
Plain-English summary
Clinical Specialties Compounding Pharmacy, located in Augusta, Georgia, is recalling 12ml vials of Test cyp 50 mg/ml. The specific lot number is CABCCHBB:81, with an expiration date of 5/26/2013. The product was distributed in Florida, Georgia, and South Carolina.
The recall was initiated following FDA inspection findings that raised concerns regarding the quality control processes used by the pharmacy. Specifically, the agency identified a lack of assurance of sterility for the product.
Consumers who have this specific lot of Test cyp 50 mg/ml should stop using it and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- Test cyp 50 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907
- Manufacturer
- Clinical Specialties Compounding Pharmacy
- Category
- Drug — Compounded Injectable
- Affected units
- 12
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot number CABCCHBB:81
- Exp date: 5/26/2013.
Distribution
Part of a larger recall action
This product is one of 49 recalled by Clinical Specialties Compounding Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 49 products in this recall →Related recalls
Same manufacturer · Clinical Specialties Compounding Pharmacy
See all →- SevereAvastin Syringes Recalled for Sterility Concerns and Eye Infection Reports
FDA (Drugs) · 2013-09-04
- SevereEstradiol Cypionate Injection Recalled Due to Sterility Concerns
FDA (Drugs) · 2013-07-10
- SevereClinical Specialties Compounding Pharmacy Recalls Test Cyp 200 mg/ml Due to Sterility Concerns
FDA (Drugs) · 2013-07-10
- SevereClinical Specialties Compounding Pharmacy Recalls Test Cyp 100 mg/ml Due to Sterility Concerns
FDA (Drugs) · 2013-07-10
- SevereAcetylcysteine 2% Solution Recalled Due to Sterility Concerns
FDA (Drugs) · 2013-07-10
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereTestosterone Cypionate Injection Recalled Due to Sterility Concerns
FDA (Drugs) · 2015-09-23
- SevereTestosterone Cypionate Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2014-03-12
- SevereWell Care Compounding Pharmacy Recalls Testosterone Cypionate Due to Sterility Concerns
FDA (Drugs) · 2016-06-15
- SevereKey Pharmacy Recalls Testosterone Cypionate Injections Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereTestosterone Cypionate Injectable Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- Severe